Health

Tech-Health-Explore: Breaking Down the Companies Tracking Our Bodies

Exploring Exicure, Part 1 – An Introduction

As a rule, we follow the technological advancements of corporate giants in tech health to help inform those of us individuals choosing to define for ourselves who we are and what we want to be. That means knowing the world and those tracking us, good and bad. Incredible advancements are made every day by health companies seeking to do good in the world, no doubt. However, we need to follow and examine them to enhance our own capabilities and positioning. We are not victims, we are active agents in our lives. In this new topic within the theme, we are exploring a company primed to give us the safe/effective delivery of nucleic acid therapies right into our cells and tissues that we’ve been waiting for since the dawn of the century.

Cyberpunk is Loaded

Perhaps there are few elements as common to the genre of cyberpunk as the expansive and ever-growing list of drug therapies used to enhance any number of human characteristics. Don’t believe us, just check out the Big Book of Drugs created for Cyberpunk 2.0.2.0. And its not just about the feel good variety, much of it is dedicated to advancing human health and ability.

Technologically Enhanced Therapies

For the real-life version in the 21st century, perhaps there is no better use of drugs, than to try our hands at therapies built upon nucleic acids. You know the stuff at the center of DNA and RNA. After all, what better to help chance the course of humanity in terms of health than to tinker with our DNA and RNA, right? Even Jurassic Park taught us this…

Thanks BadfishKoo

Those core elements of DNA and RNA, nucleic acids, offer us the ability to provide new coding into our cells and create a pathway for new health therapies across a number of human ailments and desires. As far back as the year 2000, scientists were publishing in the scientific journal Nature describing that the impact of such technology in the area of immunology and cancer research using nucleic acids a vaccines would “undoubtedly be one of the most important advances in the history of vaccinology.” For the longest time, however, getting these therapies to uptake into the body’s cells and tissues was a difficult task.

Partnering to Produce

Fast forward twenty years and there are a number of publicly-traded companies that are working on exactly this problem and making dramatic breakthroughs.

The newcomers are quickly finding themselves a number of very willing and interested partners. More importantly, they are finding a quality stream of cash-flow to really push development.

Within this field of partnered-up biotechs, we also find Exicure. Their own partnership being with $187.378B Abbvie Inc’s (as of 3/9/21 on Yahoo! Finance) subsidiary Allergan, the maker of Botox.

The Exicure Difference

What separates Exicure from the rest of those companies partnering with larger, more established biotechs, is that Exicure stands alone as the only to be platform agnostic. Big fancy tech words, I know, simply put – it works well across a number of platforms.

Not limited to a single design technology in nucleic acid therapy, Exicure works across a number of them making the applications far more widespread and scalable. Ultimately, this means development into a number of fields including neurology, immuno-oncology (getting the body’s own immune system to fight cancer), dermatology, ophthalmology, GI tract, lung, and liver therapies.

Scratching the Surface & Closing, If Only For Today

While we’ve only just begun our investigation into Exicure we are going to leave off here for today. Always better to let new info settle in.

In any case, next week, we’ll continue our dive and breakdown the tech a little further. We’ll look to see what Exicure is proposing and how they are already making inroads to success.

As always, make sure we are thinking for ourselves out there, doing our own homework, and cyberize our lives with the best in disruptive tech. We aren’t doctors or professional investors, we’re just the average guy out there in the free flow of the masses looking for understanding and wanting to share. For those fueled by health-tech make sure to explore our BCB Cyber Health Section in more detail! See you next time on BCB Cyber.

Brian C. Briggs

Share
Published by
Brian C. Briggs

Recent Posts

The Return

Greetings All... Just wanted to say, we'll be back... on August 1, 2022!

2 years ago

On Break

05.25.21 Good Morning Everyone! As of today we will begin a two-week break, but we…

3 years ago

Top Tech Stocks: Dividend Payer Edition Norilsk Nickel (NILSY)

Good Monday everyone and welcome to the BCB Cyber Series that takes on the tech…

3 years ago

Skyscrapers & Skylines: Wuhan

05.23.21 GIF’d Up Cityscape: GIF’d Up Cityscape: Wuhan, capital of Hubei Province, PRC (People's Republic…

4 years ago

Bullz or Bearz??? & MORE!!!

WAZZUP Y'ALL?!?!? Welcome back, everyone. The workweek was shit; we all know that, but hey,…

4 years ago

Cyber-Zen Friday 05.21.21

Our dystopian life now… Which high tech, low life story will we write today?

4 years ago

This website uses cookies.